Biotech Values

[rkrw]

My impression is Fragmin was a bit more challenging and they didn't succeed. Given the low commercial sales i'm not sure why they bothered in the first place. Back when Crane was ceo he talked about pulling in a partner which never happened. If one of the first three had to fail, this is obviously the one you'd want to see.